Copyright Reports & Markets. All rights reserved.

Global Cardiac Rhythm Management Devices Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Cardiac Rhythm Management Devices Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Cardiac Rhythm Management Devices Market Size Growth Rate by Product
      • 1.4.2 Implantable Defibrillators
      • 1.4.3 Bi Ventricular Pacemakers
    • 1.5 Market by End User
      • 1.5.1 Global Cardiac Rhythm Management Devices Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Home Settings
      • 1.5.5 ASCs
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Cardiac Rhythm Management Devices Market Size
      • 2.1.1 Global Cardiac Rhythm Management Devices Revenue 2014-2025
      • 2.1.2 Global Cardiac Rhythm Management Devices Sales 2014-2025
    • 2.2 Cardiac Rhythm Management Devices Growth Rate by Regions
      • 2.2.1 Global Cardiac Rhythm Management Devices Sales by Regions
      • 2.2.2 Global Cardiac Rhythm Management Devices Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Cardiac Rhythm Management Devices Sales by Manufacturers
      • 3.1.1 Cardiac Rhythm Management Devices Sales by Manufacturers
      • 3.1.2 Cardiac Rhythm Management Devices Sales Market Share by Manufacturers
      • 3.1.3 Global Cardiac Rhythm Management Devices Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cardiac Rhythm Management Devices Revenue by Manufacturers
      • 3.2.1 Cardiac Rhythm Management Devices Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cardiac Rhythm Management Devices Revenue Share by Manufacturers (2014-2019)
    • 3.3 Cardiac Rhythm Management Devices Price by Manufacturers
    • 3.4 Cardiac Rhythm Management Devices Manufacturing Base Distribution, Product Types
      • 3.4.1 Cardiac Rhythm Management Devices Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Cardiac Rhythm Management Devices Product Type
      • 3.4.3 Date of International Manufacturers Enter into Cardiac Rhythm Management Devices Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Cardiac Rhythm Management Devices Sales by Product
    • 4.2 Global Cardiac Rhythm Management Devices Revenue by Product
    • 4.3 Cardiac Rhythm Management Devices Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Cardiac Rhythm Management Devices Breakdown Data by End User

    6 North America

    • 6.1 North America Cardiac Rhythm Management Devices by Countries
      • 6.1.1 North America Cardiac Rhythm Management Devices Sales by Countries
      • 6.1.2 North America Cardiac Rhythm Management Devices Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Cardiac Rhythm Management Devices by Product
    • 6.3 North America Cardiac Rhythm Management Devices by End User

    7 Europe

    • 7.1 Europe Cardiac Rhythm Management Devices by Countries
      • 7.1.1 Europe Cardiac Rhythm Management Devices Sales by Countries
      • 7.1.2 Europe Cardiac Rhythm Management Devices Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Cardiac Rhythm Management Devices by Product
    • 7.3 Europe Cardiac Rhythm Management Devices by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Cardiac Rhythm Management Devices by Countries
      • 8.1.1 Asia Pacific Cardiac Rhythm Management Devices Sales by Countries
      • 8.1.2 Asia Pacific Cardiac Rhythm Management Devices Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Cardiac Rhythm Management Devices by Product
    • 8.3 Asia Pacific Cardiac Rhythm Management Devices by End User

    9 Central & South America

    • 9.1 Central & South America Cardiac Rhythm Management Devices by Countries
      • 9.1.1 Central & South America Cardiac Rhythm Management Devices Sales by Countries
      • 9.1.2 Central & South America Cardiac Rhythm Management Devices Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Cardiac Rhythm Management Devices by Product
    • 9.3 Central & South America Cardiac Rhythm Management Devices by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Cardiac Rhythm Management Devices by Countries
      • 10.1.1 Middle East and Africa Cardiac Rhythm Management Devices Sales by Countries
      • 10.1.2 Middle East and Africa Cardiac Rhythm Management Devices Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Cardiac Rhythm Management Devices by Product
    • 10.3 Middle East and Africa Cardiac Rhythm Management Devices by End User

    11 Company Profiles

    • 11.1 Boston Scientific
      • 11.1.1 Boston Scientific Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Boston Scientific Cardiac Rhythm Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Boston Scientific Cardiac Rhythm Management Devices Products Offered
      • 11.1.5 Boston Scientific Recent Development
    • 11.2 Medtronic
      • 11.2.1 Medtronic Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Medtronic Cardiac Rhythm Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Medtronic Cardiac Rhythm Management Devices Products Offered
      • 11.2.5 Medtronic Recent Development
    • 11.3 St. Jude Medical
      • 11.3.1 St. Jude Medical Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 St. Jude Medical Cardiac Rhythm Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 St. Jude Medical Cardiac Rhythm Management Devices Products Offered
      • 11.3.5 St. Jude Medical Recent Development
    • 11.4 Altera
      • 11.4.1 Altera Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Altera Cardiac Rhythm Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Altera Cardiac Rhythm Management Devices Products Offered
      • 11.4.5 Altera Recent Development
    • 11.5 Biotronik
      • 11.5.1 Biotronik Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Biotronik Cardiac Rhythm Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Biotronik Cardiac Rhythm Management Devices Products Offered
      • 11.5.5 Biotronik Recent Development

    12 Future Forecast

    • 12.1 Cardiac Rhythm Management Devices Market Forecast by Regions
      • 12.1.1 Global Cardiac Rhythm Management Devices Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Cardiac Rhythm Management Devices Revenue Forecast by Regions 2019-2025
    • 12.2 Cardiac Rhythm Management Devices Market Forecast by Product
      • 12.2.1 Global Cardiac Rhythm Management Devices Sales Forecast by Product 2019-2025
      • 12.2.2 Global Cardiac Rhythm Management Devices Revenue Forecast by Product 2019-2025
    • 12.3 Cardiac Rhythm Management Devices Market Forecast by End User
    • 12.4 North America Cardiac Rhythm Management Devices Forecast
    • 12.5 Europe Cardiac Rhythm Management Devices Forecast
    • 12.6 Asia Pacific Cardiac Rhythm Management Devices Forecast
    • 12.7 Central & South America Cardiac Rhythm Management Devices Forecast
    • 12.8 Middle East and Africa Cardiac Rhythm Management Devices Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Cardiac Rhythm Management Devices Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Cardiac rhythm management devices continue to evolve rapidly in form factor, reliability and lifespan. Even as implantable designs become increasingly compact and functional, they are introducing groundbreaking new elements like leadless pacing and integrated fixation concepts for minimally invasive deployment. Cardiac rhythm management devices such as pacemakers, implantable cardiac defibrillators (ICDs) and CRT devices are all getting smaller, smarter and longer-lasting.
      Rise in cholesterol levels, hypertension, and excessive smoking lead to high risks of cardiac disorders, resulting in the growing need for cardiovascular therapeutic instruments such as CRT devices. Governments and organizations in many countries implement various initiatives to educate and help people to make medical decisions, increase public awareness, and improve the quality of life. Pacemakers, ICDs, and CRT devices are used to treat arrhythmias and are considered as a standard treatment option in many countries.       
      North America is expected to have the largest market share for cardiac rhythm management, due to developed healthcare infrastructure, government initiatives, rising number of death due to cardiovascular diseases, and rising incidence of arrhythmias demanding more cardiac implants. According to a report by the US CDC, more than 75,000 hospitalizations are attributed atrial fibrillation. Also, it highlighted that a large part of the American population suffers from atrial fibrillation. Therefore, it is expected to rise further in the forecast period. Asia-Pacific is another region with high potential for this market, due to rising healthcare expenditure by government, increasing the prevalence of cardiac disorders, and growing per capita income of population in South Asian countries.
      The global Cardiac Rhythm Management Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiac Rhythm Management Devices market based on company, product type, end user and key regions.

      This report studies the global market size of Cardiac Rhythm Management Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiac Rhythm Management Devices in these regions.
      This research report categorizes the global Cardiac Rhythm Management Devices market by top players/brands, region, type and end user. This report also studies the global Cardiac Rhythm Management Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Boston Scientific
      Medtronic
      St. Jude Medical
      Altera
      Biotronik

      Market size by Product
      Implantable Defibrillators
      Bi Ventricular Pacemakers
      Market size by End User
      Hospitals
      Clinics
      Home Settings
      ASCs

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Cardiac Rhythm Management Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Cardiac Rhythm Management Devices market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Cardiac Rhythm Management Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Cardiac Rhythm Management Devices submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Cardiac Rhythm Management Devices are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiac Rhythm Management Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now